Key Takeaways
- BEUC and ANEC have formally challenged the European Commission’s reliance on industry-led standards for AI-integrated medical devices and children’s toys.
- The proposed framework delegates safety definitions to private standardisation bodies like CEN-CENELEC, which civil society argues lacks the democratic oversight of direct legislation.
- Enterprises operating in the EU must now navigate a dual-track risk profile where technical compliance alone may not provide sufficient protection against consumer rights litigation. Europe’s landmark AI Act may have its safety guarantees written in law, but the rules that actually determine whether a product is safe are being drafted elsewhere — by private industry bodies with limited public oversight. This week, BEUC (The European Consumer Organisation) and ANEC issued a formal warning that this arrangement risks hollowing out the AI Act’s protections before the law fully takes effect, particularly for AI-enabled medical devices and internet-connected toys. At the heart of the dispute is a deceptively simple question: who gets to define “safe”?
Frameworks for Comparison: Assessing AI Compliance Pathways
To understand the weight of the civil society warning, it helps to compare the two primary pathways for demonstrating AI safety in the European market. For manufacturers of medical devices and toys, the choice of compliance strategy affects everything from R&D costs to long-term legal liability. The comparison turns on five criteria relevant to enterprise stakeholders:
- Regulatory Rigour: The depth of scrutiny applied to the AI’s underlying algorithms, training data and failure modes.
- Cost of Compliance: The total expenditure required for testing, documentation and external auditing.
- Speed to Market: The time required to navigate the regulatory process from prototype to commercial launch.
- Legal Risk Mitigation: The extent to which the compliance pathway protects the firm from future litigation or regulatory fines.
- Scalability: How easily the compliance framework can be applied across a diverse portfolio of AI-enabled products.
The Industry-Led Approach: Harmonised Technical Standards
The first pathway relies on harmonised standards developed by CEN-CENELEC — the European Committee for Standardization and its electrotechnical counterpart. Under the EU AI Act, products conforming to these standards receive a “presumption of conformity,” meaning that following the technical checklist is treated as legally equivalent to meeting the Act’s safety requirements.
Industry groups favour this approach because it provides a clear technical roadmap for engineering teams and allows for a more streamlined self-assessment process across many product categories. For an enterprise developing an AI-enabled diagnostic tool or a smart toy, following a CEN-CENELEC standard is generally the most cost-effective route. Documentation is standardised, testing protocols are predictable, and internal resource demands are manageable compared to bespoke audits.
This is precisely where civil society groups have raised their objections. CEN and CENELEC are private organisations where industry representatives hold the majority of seats. When those bodies define what “safe” looks like for an AI-powered insulin pump or a child’s educational robot, critics argue that technical feasibility and cost-reduction can be prioritised over absolute safety. From an enterprise perspective, the industry-led pathway offers the fastest route to market — but it may leave companies exposed to compliance gaps: situations where a product meets the technical standard yet still causes harm, triggering reputational damage and potential strict liability claims under the revised Product Liability Directive.
The Independent Pathway: Third-Party Conformity Assessment
The second pathway requires mandatory third-party conformity assessment conducted by notified bodies — independent organisations officially designated by EU member states to evaluate product compliance. For the highest-risk AI systems, particularly in the medical field where a failure could result in death or permanent injury, both the AI Act and the Medical Devices Regulation (MDR) frequently mandate this more rigorous route.
Unlike self-assessment, third-party assessment requires the manufacturer to submit a complete AI technical file — covering data governance policies, transparency measures and human oversight protocols — to an external auditor who evaluates the effectiveness of the risk management system, not just whether boxes have been ticked. This pathway is significantly more expensive and can add months or years to the product development lifecycle.
From a risk mitigation standpoint, however, it remains the gold standard. Passing a notified body audit demonstrates that safety claims have been validated by an impartial expert, providing a more robust legal defence than self-certification. Civil society groups are pushing for a broader range of AI products — including all AI toys and a wider array of medical software — to be moved into this mandatory category. They argue that the complexity and opacity of modern large language models and neural networks make industry-led self-assessment inherently unreliable.
Comparison Summary: Efficiency versus Accountability
The choice between these two approaches represents a fundamental trade-off between commercial efficiency and public accountability. The industry-led standards approach offers a scalable, predictable environment for AI innovation, and for enterprises managing large product portfolios, the ability to apply a single set of technical standards across multiple lines carries real operational value.
The independent assessment pathway prioritises safety over speed, and addresses the information asymmetry that exists between a technology company and the general public. The warning from BEUC and ANEC this week makes clear that if the industry-led approach is seen as insufficiently robust, it will likely face a wave of strategic litigation from consumer groups — effectively undermining the presumption of conformity that companies are counting on.
For enterprise automation, the calculus is straightforward in higher-risk sectors: in medical devices, where the cost of a product recall can far exceed the cost of development, the more rigorous compliance pathway frequently proves to be the more fiscally responsible choice over a longer horizon.
Recommendations for Enterprise AI Strategy
Given the sustained pressure from civil society and the real possibility that the European Commission will be pushed toward tighter standards, enterprises should not wait for the final publication of harmonised standards before beginning their compliance work. A proactive stance is essential. Companies developing AI products in regulated sectors may also find it useful to review the compliance risks already emerging under EU AI enforcement as enforcement timelines begin to crystallise.
First, companies should adopt what might be called an MDR-Plus approach to AI development — using the existing Medical Devices Regulation as a baseline for all high-risk AI, even where a product currently falls under a lower-risk category such as smart toys. Building data lineage, bias detection and explainability into a product from day one ensures the company is prepared if the Commission upgrades the risk classification of its products in response to civil society pressure.
Second, enterprises should engage directly with the standardisation process. Rather than delegating representation to trade associations, companies should ensure their internal safety engineers are participating in CEN-CENELEC technical committees. Direct involvement allows firms to track the direction of standards before they are finalised and to advocate for requirements that are both technically rigorous and commercially viable.
Finally, for any AI product involving vulnerable users — children or patients with chronic conditions — enterprises should consider voluntary third-party auditing. Even where the law permits self-assessment, an independent validation serves as a meaningful market differentiator and a proactive defence against the safety criticisms raised by BEUC and ANEC this week. In the current regulatory climate, legal compliance is the floor; demonstrable safety is what protects enterprise value over time. For more coverage of AI policy and regulation, visit our AI Policy & Regulation section.
Originally published at https://autonainews.com/civil-society-groups-fight-eu-ai-act-safety-cuts-for-consumer-goods/
Top comments (0)